Hepatic Elastography in the Assessment of Heart Failure: Where We Came from and Where We Are Going
Congestive heart failure (HF) is the end stage for many cardiac diseases. It is associated with high mortality and high hospital readmission rates, despite advances in pharmacological (sacubitril‑losartan, beta-blockers and renin-angiotensin system inhibitors) and non-pharmacological (defibrillators and resynchronizers) treatment. Therefore, it is natural that clinicians are interested in the improvement of diagnostic methods and eficiente prognostic markers capable of identifying patients at higher risk, thus anticipating complications and providing treatment guidance.
Keywords: Heart Failure; Elasticity Imaging Techniques/methods; Hospitalization; Outcomes; Patient Readmission; Prognosis; Liver Diseases.